Atlas Trials

Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis

Clinical trial NCT00449397 · COMPLETED

Trial details

NCT number
NCT00449397
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psychosis
Start date
2003-07-01
Primary completion
2006-01-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.